QUAKER CHEMICAL CORP·4

Nov 18, 4:28 PM ET

STEEPLES ADRIAN 4

4 · QUAKER CHEMICAL CORP · Filed Nov 18, 2020

Insider Transaction Report

Form 4
Period: 2020-11-16
STEEPLES ADRIAN
VP & Managing Director - A/P
Transactions
  • Exercise/Conversion

    Common Stock

    2020-11-16$151.75/sh+1,228$186,3497,703 total
  • Sale

    Common Stock

    2020-11-16$254.14/sh76$19,3157,392 total
  • Sale

    Common Stock

    2020-11-16$256.70/sh282$72,3896,870 total
  • Sale

    Common Stock

    2020-11-16$257.65/sh368$94,8156,502 total
  • Sale

    Common Stock

    2020-11-16$258.94/sh27$6,9916,475 total
  • Sale

    Common Stock

    2020-11-16$255.53/sh240$61,3277,152 total
  • Sale

    Common Stock

    2020-11-16$251.83/sh91$22,9177,612 total
  • Sale

    Common Stock

    2020-11-16$253.08/sh144$36,4447,468 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2020-11-161,228613 total
    Exercise: $151.75Exp: 2025-02-26Common Stock (1,228 underlying)
Footnotes (7)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.44 to $252.03, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.58 to $253.47, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.72 to $254.96, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.13 to $255.99, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.20 to $257.14, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.26 to $258.22, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4.
  • [F7]The options for this grant vest in three annual installments: 614 shares on February 26, 2019; 614 shares on February 26, 2020; and 613 shares on February 26, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION